Innovation Medical Management Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Innovation Medical Management Co., Ltd. (formerly Qianzu Pearl Group Co., Ltd.) was founded in April 1997 and completed its initial public offering and listing on September 25, 2007. The securities were abbreviated as "Qianzu Pearl". The company was renamed as "Innovation Medical Management Co., Ltd." in June 2016, and the securities code was changed to "Innovation Medical". On September 23, 2015, Qianzu Pearl announced the "Qianzu Pearl Group Co., Ltd. Issued Shares to Purchase Assets and Raised Supporting Funds and Related Party Transactions Report", which was approved by the China Securities Regulatory Commission on November 24, 2015. Through this transaction, the three target hospitals will become wholly-owned subsidiaries of Qianzu Pearl and be included in the consolidated financial statements of Qianzu Pearl. The company integrates resources based on the advantages of each of the three hospitals, and introduces the excellent management model of listed companies to achieve resource sharing and complementary advantages among each hospital. After the completion of this transaction, the target hospital will effectively improve its brand awareness and social influence through capital market operations. At the same time, it will leverage the smooth financing channels of the listed company to quickly expand its business scale and seize the medical service industry market. Hospitals, due to their own characteristics, have the advantages of relatively stable operation, strong anti cyclical ability, and good cash flow, which is conducive to building a business portfolio with low cyclical fluctuation risk and broad prospects for listed companies. With the continuous deepening of the reform of the medical service industry, excellent private hospitals will achieve rapid development, and the profitability of the target hospital will continue to steadily improve in the following years. After the completion of this transaction, the injection of high-quality assets will significantly enhance the profitability of the listed company, thereby maximizing shareholder value. In the future, the company will be based on existing medical service resources and brand advantages, seize the market and investment opportunities of further opening up social capital medical services in China, continue to increase investment in the medical service field, build a strategic layout of medical service business that combines high-end medical services in developed cities, specialized and comprehensive hospitals in second and third tier cities, continuously expand the scale of medical services, and gradually develop into a first-class medical service group in China. |
| Headquarter | Shaoxing |
| Establish Date | 9/30/2003 |
| Listed Code | 002173.SZ |
| Listed Date | 9/25/2007 |
| Chairman | Chen Haijun. |
| CEO | Ma Jianjian. |
| Website | www.chxyl.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
